Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sodium lactate + calcium chloride + potassium chloride + sodium chloride + dextrose** is a fixed-composition intravenous crystalloid solution marketed as Lactated Ringer's and Dextrose (5%) Injection. It combines sodium, potassium, calcium, chloride, lactate, and 5% dextrose to replace extracellular water and electrolytes while providing limited carbohydrate calories. Lactate is metabolized to bicarbonate equivalents and can support alkalinization; the solution has no single pharmacologic receptor target. It is used intravenously in adult and pediatric patients as a source of water, electrolytes, and calories, and as an alkalinizing agent. The labeled formulation contains dextrose 5 g, sodium chloride 600 mg, sodium lactate 310 mg, potassium chloride 30 mg, and calcium chloride 20 mg per 100 mL, and is hypertonic. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6acc9f96-7088-45a7-b48f-1a861e3467ab))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium lactate + calcium chloride + potassium chloride + sodium chloride + dextrose.